LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Pioneering Automated COVID-19 Test Robot Can Process 20,000 Samples for SARS-CoV-2 Testing Per 24 Hours

By LabMedica International staff writers
Posted on 04 Feb 2021
Print article
Image: Pioneering Automated COVID-19 Test Robot Can Process 20,000 Samples for SARS-CoV-2 Testing Per 24 Hours (Photo courtesy of Hubrecht Institute)
Image: Pioneering Automated COVID-19 Test Robot Can Process 20,000 Samples for SARS-CoV-2 Testing Per 24 Hours (Photo courtesy of Hubrecht Institute)
A new COVID-19 test robot can process up to 20,000 samples for SARS-CoV-2 testing per 24 hours, making it much faster than all other systems used to date.

The robot, called STRIP-1, developed by scientists at the Hubrecht Institute (Utrecht, the Netherlands) and Genmab (Copenhagen, Denmark) can not only process more tests in less time than any other machine known to date, but can also track all samples precisely, because they have a barcode that is scanned multiple times throughout the process. This also enables an automatic online return of test results to the tested persons. Because STRIP-1 can work with very small volumes, it uses less of the materials that are currently very scarce across the world. The costs per test will also be much lower than current testing costs. Lastly, using STRIP-1 will relieve overloaded laboratory personnel.

After successfully going through the validation procedure, the robot will be used for large scale testing. The Dutch government plans to order five more of such robots in the future, if the validation procedure indeed delivers the expected results. Together, these robots will be able to process more than 100,000 samples per 24 hours. The robots are not only useful during the current COVID-19 pandemic, but due to their modular structure, they can also be used for future pandemics. This enables large scale testing immediately, without overloading the regular diagnostic laboratories.

“While we were working on this, we realized that the gold standard of tests, the PCR test, works extremely well and that the biggest challenge was the logistics of it all,” said Wouter de Laat, one of the initiators of the project. “We hoped that we could organize everything in a faster and more intelligent way by using robots, so that became our focus almost immediately.”

Related Links:
Hubrecht Institute
Genmab


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Vaginitis Test
Allplex Vaginitis Screening Assay
New
Binocular Laboratory LED Illuminated Microscope
HumaScope Classic LED

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.